1.             Introduction

1.1       Scope of the Study

1.2       The Insight Partners Research Report Guidance

1.3       Market Segmentation

1.3.1        North America Exosome diagnostic and therapeutic Market – By Application

1.3.2        North America Exosome diagnostic and therapeutic Market – By Product

1.3.3        North America Exosome diagnostic and therapeutic Market – By End User

1.3.4        North America Exosome Diagnostic and Therapeutic Market – By Country

2.             Exosome Diagnostic and Therapeutic Market – Key Takeaways

3.             Research Methodology

3.1       Coverage

3.2       Secondary Research

3.3       Primary Research

4.             North America Exosome Diagnostic and Therapeutic Market – Market Landscape

4.1       Overview

4.2       Pest Analysis

4.2.1        North America – PEST Analysis

5.             North America Exosome Diagnostic and Therapeutic Market – Key Market Dynamics

5.1       Key Market Drivers

5.1.1        Greater Precision and Advantages over Traditional Methods of Diagnosis and Therapeutics

5.1.2        Rise in Research and Development Activities

5.2       Key Market Restraints

5.2.1        Poor Infrastructure and Lack of Expertise Required for Isolation of Exosomes

5.3       Key Market Opportunities

5.3.1        Growing Preference for Non-invasive and Novel Diagnostic Procedures

5.4       Future Trends

5.4.1        Automation of Exosome Isolation Process

5.5       Impact analysis

6.             Exosome Diagnostic and Therapeutic Market– Regional Analysis

6.1       North America Exosome Diagnostic and Therapeutic Market Revenue Forecast and Analysis

7.             Exosome Diagnostic and Therapeutic Market Analysis – By Application

7.1       Overview

7.2       Exosome Diagnostic and Therapeutic Market Share, by Application, 2019 and 2027 (%)

7.3       Diagnostic

7.3.1        Overview

7.3.2        Diagnostic: Exosome Diagnostic and Therapeutic Market– Revenue and Forecast to 2027  (US$ Thousand)

7.4       Therapeutic

7.4.1        Overview

7.4.2        Therapeutic: Exosome Diagnostic and Therapeutic Market– Revenue and Forecast to 2027  (US$ Thousand)

8.             Exosome Diagnostic and Therapeutic Market Analysis – By Product

8.1       Overview

8.2       Exosome Diagnostic and Therapeutic Market Share, by Product, 2019 and 2027, (%)

8.3       Instruments

8.3.1        Overview

8.3.2        Instruments: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027  (US$ Thousand)

8.4       Reagents

8.4.1        Overview

8.4.2        Reagents: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)

8.5       Software

8.5.1        Overview

8.5.2        Software: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)

9.             Exosome Diagnostic and Therapeutic Market Analysis – By End User

9.1       Overview

9.2       Exosome Diagnostic and Therapeutic Market Share, by End User, 2019 and 2027, (%)

9.3       Cancer Institutes

9.3.1        Overview

9.3.2        Cancer Institutes: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027  (US$ Thousand)

9.4       Hospitals

9.4.1        Overview

9.4.2        Hospitals: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)

9.5       Diagnostic Centres

9.5.1        Overview

9.5.2        Diagnostic Centres: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027  (US$ Thousand)

9.6       Other End User

9.6.1        Overview

9.6.2        Other End Users: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027  (US$ Thousand)

10.          Exosome Diagnostic and Therapeutic Market – Geographic Analysis

10.1    North America: Exosome Diagnostic and Therapeutic Market

10.1.1     Overview

10.1.2     North America: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027  (USD Thousand)

10.1.3     North America: Exosome Diagnostic and Therapeutic Market, by Application, 2018–2027  (USD Thousands)

10.1.4     North America: Exosome Diagnostic and Therapeutic Market, by Product, 2018–2027 (USD Thousand)

10.1.5     North America: Exosome Diagnostic and Therapeutic Market, by End User, 2018–2027 (USD Thousand)

10.1.6     North America: Exosome Diagnostic and Therapeutic Market, by Country, 2019& 2027 (%)

10.1.7     US: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)

10.1.7.1    US: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)

10.1.7.2    US: Exosome Diagnostic and Therapeutic Market, by Application, 2018–2027 (USD Thousand)

10.1.7.3    US: Exosome Diagnostic and Therapeutic Market, by Product, 2018–2027 (USD Thousand)

10.1.7.4    US: Exosome Diagnostic and Therapeutic Market, by End User, 2018–2027 (USD Thousand)

10.1.8     Canada: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)

10.1.8.1    Canada: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)

10.1.8.2    Canada: Exosome Diagnostic and Therapeutic Market, by Application, 2018–2027 (USD Thousand)

10.1.8.3    Canada: Exosome Diagnostic and Therapeutic Market, by Product, 2018–2027 (USD Thousand)

10.1.8.4    Canada: Exosome Diagnostic and Therapeutic Market, by End User, 2018–2027 (USD Thousand)

10.1.9     Mexico: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)

10.1.9.1    Mexico: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)

10.1.9.2    Mexico: Exosome Diagnostic and Therapeutic Market, by Application, 2018–2027 (USD Thousand)

10.1.9.3    Mexico: Exosome Diagnostic and Therapeutic Market, by Product, 2018–2027 (USD Thousand)

10.1.9.4    Mexico: Exosome Diagnostic and Therapeutic Market, by End User, 2018–2027 (USD Thousand)

11.          Impact Of Covid-19 Pandemic On North America Exosome Diagnostic And Therapeutic Market

11.1    North America: Impact assessment of COVID-19 Pandemic

12.          Exosome Diagnostic and Treatment Market –Industry Landscape

12.1    Overview

12.2    Growth Strategies in The Exosome Diagnostic And Treatment Market, 2017-2020

12.3    Inorganic Growth Strategies

12.3.1     Overview

12.4    Organic Growth Strategies

12.4.1     Overview

13.          COMPANY PROFILES

13.1    Cell Guidance Systems

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2    BIOREGENERATIVE SCIENCES

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3    Evomic Science LLC

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4    Norgen Biotek Corp

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5    Miltenyi Biotec

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6    Therapeutic Solutions International, Inc.

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     SWOT Analysis

13.6.5     Key Developments

13.7    AETHLON MEDICAL, INC

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8    RENEURON GROUP PLC

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

13.9    ITH, Immune Therapy Holdings AB

13.9.1     Key Facts

13.9.2     Business Description

13.9.3     Products and Services

13.9.4     Financial Overview

13.9.5     SWOT Analysis

13.9.6     Key Developments

13.10 EXOSOME DIAGNOSTICS

13.10.1   Key Facts

13.10.2   Business Description

13.10.3   Products and Services

13.10.4   Financial Overview

13.10.5   SWOT Analysis

13.10.6   Key Developments

14.          Appendix

14.1    About the Insight Partners

14.2    Glossary of Terms

LIST OF TABLES

Table 1.             North America Exosome Diagnostic and Therapeutic Market, by Application– Revenue and Forecast to 2027  (USD Thousands)

Table 2.             North America Exosome Diagnostic and Therapeutic Market, by Product – Revenue and Forecast to 2027 (USD Thousand)

Table 3.             North America Exosome Diagnostic and Therapeutic Market, by End User – Revenue and Forecast to 2027  (USD Thousand)

Table 4.             US Exosome Diagnostic and Therapeutic Market, by Application– Revenue and Forecast to 2027  (USD Thousand)

Table 5.             US Exosome Diagnostic and Therapeutic Market, by Product – Revenue and Forecast to 2027 (USD Thousand)

Table 6.             US Exosome Diagnostic and Therapeutic Market, by End User – Revenue and Forecast to 2027 (USD Thousand)

Table 7.             Canada Exosome Diagnostic and Therapeutic Market, by Application– Revenue and Forecast to 2027  (USD Thousand)

Table 8.             Canada Exosome Diagnostic and Therapeutic Market, by Product – Revenue and Forecast to 2027  (USD Thousand)

Table 9.             Canada Exosome Diagnostic and Therapeutic Market, by End User – Revenue and Forecast to 2027  (USD Thousand)

Table 10.          Mexico Exosome Diagnostic and Therapeutic Market, by Application– Revenue and Forecast to 2027  (USD Thousand)

Table 11.          Mexico Exosome Diagnostic and Therapeutic Market, by Product – Revenue and Forecast to 2027 (USD Thousand)

Table 12.          Mexico Exosome Diagnostic and Therapeutic Market, by End User – Revenue and Forecast to 2027  (USD Thousand)

Table 14.          Recent Inorganic Growth Strategies in The Exosome Diagnostic and Treatment Market

Table 15.          Recent Organic Growth Strategies in The Exosome Diagnostic and Treatment Market

Table 16.          Glossary of Terms, Exosome diagnostic and treatment market

LIST OF FIGURES

Figure 1.           Exosome Diagnostic and Therapeutic Market Segmentation

Figure 2.           Exosome Diagnostic and Therapeutic Segmentation, By Country

Figure 3.           North America Exosome Diagnostic and Therapeutic Market Overview

Figure 4.           Diagnostics Held Largest Share of Application Segment in Exosome diagnostic and Therapeutic Market

Figure 5.           US Region Is Expected to Show Remarkable Growth during the Forecast Period

Figure 6.           North America Exosome Diagnostic and Therapeutic Market- Leading Country Markets (US$ Thousand)

Figure 7.           North America Exosome Diagnostic and Therapeutic Market, Industry Landscape

Figure 8.           North America PEST Analysis

Figure 9.           Exosome diagnostic and therapeutic market impact analysis of driver and restraints

Figure 10.        North America Exosome Diagnostic and Therapeutic Market– Revenue Forecast and Analysis – 2019- 2027

Figure 11.        Exosome Diagnostic and Therapeutic Market Share, by Application, 2019 and 2027 (%)

Figure 12.        Diagnostic: Exosome Diagnostic and Therapeutic Market– Revenue and Forecast to 2027 (US$ Thousand)

Figure 13.        Therapeutic: Exosome Diagnostic and Therapeutic Market– Revenue and Forecast to 2027 (US$ Thousand)

Figure 14.        Exosome Diagnostic and Therapeutic Market Share, by Product, 2019 and 2027 (%)

Figure 15.        Instruments: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027  (US$ Thousand)

Figure 16.        Reagents: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)

Figure 17.        Software: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (US$ Thousand)

Figure 18.        Exosome Diagnostic and Therapeutic Market Share, by End User, 2019 and 2027 (%)

Figure 19.        Cancer Institutes: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027  (US$ Thousand)

Figure 20.        Hospitals: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027  (US$ Thousand)

Figure 21.        Diagnostic Centers: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027  (US$ Thousand)

Figure 22.        Other End Users: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027  (US$ Thousand)

Figure 23.        North America: Exosome Diagnostic and Therapeutic Market, by Key Country – Revenue (2019) (USD Thousand)

Figure 24.        US: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)

Figure 25.        Canada: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)

Figure 26.        Mexico: Exosome Diagnostic and Therapeutic Market – Revenue and Forecast to 2027 (USD Thousand)

Figure 27.        Impact Of Covid-19 Pandemic In North American Country Markets

Figure 28.        Growth Strategies in the Exosome Diagnostic And Treatment Market, 2017-2020